{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:31:01Z","timestamp":1773271861556,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011960","name":"Debra International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011960","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011960","name":"Debra International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011960","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Matrix Biology Plus"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.mbplus.2019.100017","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T21:36:52Z","timestamp":1574199412000},"page":"100017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Generation of rabbit polyclonal human and murine collagen VII monospecific antibodies: A useful tool for dystrophic epidermolysis bullosa therapy studies"],"prefix":"10.1016","volume":"4","author":[{"given":"Olivier","family":"Bornert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Gretzmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadette","family":"Liemberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Hainzl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Koller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Nystr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mbplus.2019.100017_bb0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature24487","article-title":"Regeneration of the entire human epidermis using transgenic stem cells","volume":"551","author":"Hirsch","year":"2017","journal-title":"Nature."},{"key":"10.1016\/j.mbplus.2019.100017_bb0010","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1001\/jama.2016.15588","article-title":"Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa","volume":"316","author":"Siprashvili","year":"2016","journal-title":"JAMA."},{"key":"10.1016\/j.mbplus.2019.100017_bb0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.matbio.2018.04.001","article-title":"Epidermolysis bullosa: molecular pathology of connective tissue components in the cutaneous basement membrane zone","volume":"71\u201372","author":"Has","year":"2018","journal-title":"Matrix Biol. J. Int. Soc. Matrix Biol."},{"key":"10.1016\/j.mbplus.2019.100017_bb0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.matbio.2018.11.006","article-title":"Mutations in PLOD3, encoding lysyl hydroxylase 3, cause a complex connective tissue disorder including recessive dystrophic epidermolysis bullosa-like blistering phenotype with abnormal anchoring fibrils and type VII collagen deficiency","volume":"81","author":"Vahidnezhad","year":"2019","journal-title":"Matrix Biol. J. Int. Soc. Matrix Biol."},{"key":"10.1016\/j.mbplus.2019.100017_bb0025","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.matbio.2017.12.010","article-title":"Therapies for genetic extracellular matrix diseases of the skin","volume":"71\u201372","author":"Nystr\u00f6m","year":"2018","journal-title":"Matrix Biol. J. Int. Soc. Matrix Biol."},{"key":"10.1016\/j.mbplus.2019.100017_bb0030","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jid.2018.11.036","article-title":"Gene therapy for epidermolysis bullosa","volume":"139","author":"Marinkovich","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.mbplus.2019.100017_bb0035","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/mt.2016.199","article-title":"Gene therapy for epidermolysis bullosa: sticky business","volume":"24","author":"Nystr\u00f6m","year":"2016","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"issue":"Pt 21","key":"10.1016\/j.mbplus.2019.100017_bb0040","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1242\/jcs.112.21.3641","article-title":"Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa","volume":"112","author":"Heinonen","year":"1999","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.mbplus.2019.100017_bb0045","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI34292","article-title":"A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy","volume":"118","author":"Fritsch","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mbplus.2019.100017_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.matbio.2018.12.001","article-title":"Decorin counteracts disease progression in mice with recessive dystrophic epidermolysis bullosa","volume":"81","author":"Cianfarani","year":"2019","journal-title":"Matrix Biol. J. Int. Soc. Matrix Biol."},{"key":"10.1016\/j.mbplus.2019.100017_bb0055","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.15252\/emmm.201505061","article-title":"Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms","volume":"7","author":"Nystr\u00f6m","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mbplus.2019.100017_bb0060","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/mt.2015.58","article-title":"High local concentrations of intradermal MSCs restore skin integrity and facilitate wound healing in dystrophic epidermolysis bullosa","volume":"23","author":"K\u00fchl","year":"2015","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.mbplus.2019.100017_bb0065","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1172\/JCI68127","article-title":"Collagen VII plays a dual role in wound healing","volume":"123","author":"Nystr\u00f6m","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mbplus.2019.100017_bb0070","doi-asserted-by":"crossref","first-page":"E705","DOI":"10.1073\/pnas.1709111115","article-title":"Impaired lymphoid extracellular matrix impedes antibacterial immunity in epidermolysis bullosa","volume":"115","author":"Nystr\u00f6m","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mbplus.2019.100017_bb0075","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.jid.2016.05.115","article-title":"miR-29 regulates type VII collagen in recessive dystrophic epidermolysis bullosa","volume":"136","author":"Vanden Oever","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.mbplus.2019.100017_bb0080","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.ymthe.2017.07.005","article-title":"COL7A1 editing via CRISPR\/Cas9 in recessive dystrophic epidermolysis bullosa","volume":"25","author":"Hainzl","year":"2017","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.mbplus.2019.100017_bb0085","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.jid.2016.07.029","article-title":"Targeted exon skipping restores type VII collagen expression and anchoring fibril formation in an in vivo RDEB model","volume":"136","author":"Turczynski","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.mbplus.2019.100017_bb0090","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1038\/mtna.2016.87","article-title":"Antisense oligonucleotide-mediated exon skipping as a systemic therapeutic approach for recessive dystrophic epidermolysis bullosa","volume":"5","author":"Bremer","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.mbplus.2019.100017_bb0095","article-title":"Murine type VII collagen distorts outcome in human skin graft mouse model for dystrophic epidermolysis bullosa","author":"Bremer","year":"2018","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.mbplus.2019.100017_bb0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2133.1986.tb05707.x","article-title":"Identification of an epidermal basement membrane defect in recessive forms of dystrophic epidermolysis bullosa by LH 7:2 monoclonal antibody: use in diagnosis","volume":"115","author":"Heagerty","year":"1986","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.mbplus.2019.100017_bb0105","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/1523-1747.ep12265533","volume":"84","author":"European Society for Dermatological Research 15th Annual Meeting","year":"1985","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.mbplus.2019.100017_bb0110","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2133.1994.tb08546.x","article-title":"The epitope for anti-type VII collagen monoclonal antibody (LH7:2) locates at the central region of the N-terminal non-collagenous domain of type VII collagen","volume":"131","author":"Tanaka","year":"1994","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.mbplus.2019.100017_bb0115","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.matbio.2016.06.004","article-title":"BMP1-like proteinases are essential to the structure and wound healing of skin","volume":"56","author":"Muir","year":"2016","journal-title":"Matrix Biol. J. Int. Soc. Matrix Biol."},{"key":"10.1016\/j.mbplus.2019.100017_bb0120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.det.2009.10.011","article-title":"Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa","volume":"28","author":"Chung","year":"2010","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.mbplus.2019.100017_bb0125","first-page":"163","article-title":"Skin models for the testing of transdermal drugs","volume":"8","author":"Abd","year":"2016","journal-title":"Clin. Pharmacol. Adv. Appl."},{"key":"10.1016\/j.mbplus.2019.100017_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064243","article-title":"Rat model for dominant dystrophic epidermolysis bullosa: glycine substitution reduces collagen VII stability and shows gene-dosage effect","volume":"8","author":"Nystr\u00f6m","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mbplus.2019.100017_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177527","article-title":"Nonsense variant in COL7A1 causes recessive dystrophic epidermolysis bullosa in central Asian shepherd dogs","volume":"12","author":"Niskanen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.mbplus.2019.100017_bb0140","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1038\/jid.2011.172","article-title":"Correction of dog dystrophic epidermolysis bullosa by transplantation of genetically modified epidermal autografts","volume":"131","author":"Gache","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.mbplus.2019.100017_bb0145","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jcpa.2010.12.002","article-title":"Dystrophic epidermolysis bullosa in Assaf lambs","volume":"145","author":"P\u00e9rez","year":"2011","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.mbplus.2019.100017_bb0150","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/1523-1747.ep12470130","article-title":"Animal model for dermolytic mechanobullous disease: sheep with recessive dystrophic epidermolysis bullosa lack collagen VII","volume":"96","author":"Bruckner-Tuderman","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.mbplus.2019.100017_bb0155","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/mt.2016.92","article-title":"Analysis of the functional consequences of targeted exon deletion in COL7A1 reveals prospects for dystrophic epidermolysis bullosa therapy","volume":"24","author":"Bornert","year":"2016","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."}],"container-title":["Matrix Biology Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259002851930016X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259002851930016X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:02:50Z","timestamp":1762909370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259002851930016X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":31,"alternative-id":["S259002851930016X"],"URL":"https:\/\/doi.org\/10.1016\/j.mbplus.2019.100017","relation":{},"ISSN":["2590-0285"],"issn-type":[{"value":"2590-0285","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of rabbit polyclonal human and murine collagen VII monospecific antibodies: A useful tool for dystrophic epidermolysis bullosa therapy studies","name":"articletitle","label":"Article Title"},{"value":"Matrix Biology Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mbplus.2019.100017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100017"}}